Head of Equity Strategy
Summary: European equities are down 12% this year whereas US equities are in positive territory and emerging market equities are unchanged. But underneath the bad overall performance a tale of two different European equity markets is hiding showing that a passive approach to European equities that on all measures are extremely cheap is wrong. Investors have to be selective and in our view get exposure to the stable growth companies with high earnings predictability. Those companies will benefit more than others from the low interest rate environment.
In today’s Saxo Market Call podcast, we talked about how emerging market equities had almost fully recovered from the COVID-19 selloff whereas European equities had only recovered half of the drawdown. Asia and especially China is a big component in the emerging market index and the region seems to have managed the COVID-19 outbreak much better with their economic activity also bouncing back faster. As Europe’s rebound was under way a new resurgence in COVID-19 cases seems to be breaking the rebound playbook putting even more pressure on ECB on their Thursday press conference. You can read our ECB preview here.
Stock picking is crucial as there is no one Europe
Back in May we wrote a research note Have US equities finally peaked relative to European equities? Highlighting the grotesque difference in performance between US and European equities since 2007. Most of the outperformance is related to the facts that US companies are dominating the digital economy in the developed world and that European equity markets were still heavily overweight financials which have suffered in the post Great Financial Crisis period.
Whereas emerging market equities are almost unchanged for the year European equities are still down 12%. But Europe’s performance comes in different shades. As the table below indicates there are basically two groups this year in terms of performance. The best performing group consists of the markets: Denmark, Finland, Sweden, Netherlands, Switzerland, Germany, Portugal and Ireland which are up 1% on an equal-weight basis whereas the other group is down 20% with Austria being hit the hardest down 32% year-to-date.
| Market | Largest sector | 12m Fwd P/E | Return YTD (%) | Return 5yr (%) |
| Denmark | Health care | 16.6 | 15.6 | 46.5 |
| Finland | Industrials | 12.7 | 5.6 | 39.3 |
| Sweden | Industrials | 13.1 | 2.0 | 40.9 |
| Netherlands | Information technology | 15.6 | -1.0 | 56.1 |
| Switzerland | Health care | 15.5 | -1.5 | 35.7 |
| Germany | Consumer discretionary | 10.6 | -2.3 | 21.4 |
| Portugal | Utilities | 9.1 | -6.0 | 37.0 |
| Ireland | Materials | 13.8 | -6.0 | 8.3 |
| Norway | Financials | 7.2 | -11.3 | 28.9 |
| France | Industrials | 11.5 | -13.3 | 26.4 |
| Italy | Financials | 8.9 | -16.7 | -4.9 |
| United Kingdom | Consumer staples | 9.3 | -20.5 | 14.7 |
| Belgium | Consumer staples | 13.7 | -23.3 | -17.9 |
| Spain | Utilities | 9.5 | -24.6 | -16.6 |
| Austria | Financials | 6.9 | -31.5 | 2.1 |
Source: Bloomberg and Saxo Group
This divergence in performance is also evident in the 5-year total return numbers so this is long-term trend that has persisted indicating the tale of two European equity markets. In terms of 12-month forward P/ E ratio the best performing group has an average ratio of 13.4x which is still low given the low interest rate environment and given valuation of US equities. The worst performing group has a forward P/E ratio of 9.6 indicating very low sentiment for these markets.
Our view is that valuations are very attractive in Europe relative to many other markets but that investors should be very selective and not buy passively into European equities. As we wrote recently earnings predictability drives valuation premium, so we recommend investors to look for stable growth companies in Europe and avoid the cheap cyclicals and especially financials.
The market is trying to get back to the pre-Covid and pre-war times, but that model is broken. A new dawn is here and the financial world needs to adapt.
Steen Jakobsen,
Chief Investment Officer
A political switch in China towards less tough control of its people and companies may kick things back into gear.
Redmond Wong,
Market Strategist
While the economic situation in Europe may not be as bad as feared, there's still a plethora of things to fix.
Chris Dembik,
Head of Macroeconomic Research
As the world turns increasingly bipolar, equity markets face harsh times as they transition into the new reality.
Peter Garnry,
Head of Equity Strategy
New alliances and collaborations outside of China may lead to prosperous times in Asia.
Charu Chanana,
Market Strategist
For years, it was thought that the balanced portfolio was a thing of the past. But recent developments may have changed that.
Peter Siks,
Investment Coach
Following a dramatic and volatile 2022 with good returns, a lot of this year's commodity performance may be driven by Chinese politics.
Ole S. Hansen,
Head of Commodity Strategy
2023 could be a tough year for currencies but EUR and JPY may have some upside.
John J. Hardy,
Head of FX Strategy
The commodity-heavy Australian market may have a good start to 2023, as the Chinese focus on growth signals demand for Aussie resources.
Jessica Amir,
Market Strategist
From a near-perfect environment for speculative assets before 2022 to the opposite, crypto faces fundamental challenges.
Mads Eberhardt,
Cryptocurrency Analyst
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)
